These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases. Danis RP; Henry SP; Ciulla TA Expert Opin Pharmacother; 2001 Feb; 2(2):277-91. PubMed ID: 11336586 [TBL] [Abstract][Full Text] [Related]
23. EuroTIDES 2005--Sixth Annual IBC Conference. Oligonucleotide, RNAi and peptides for the drug development and manufacturing industry. Corey DR IDrugs; 2006 Feb; 9(2):105-6. PubMed ID: 16523398 [No Abstract] [Full Text] [Related]
25. Antisense '97: a roundtable on the state of the industry. Nat Biotechnol; 1997 Jun; 15(6):519-24. PubMed ID: 9181572 [No Abstract] [Full Text] [Related]
26. Cell membranes as barriers for the use of antisense therapeutic agents. Jääskeläinen I; Urtti A Mini Rev Med Chem; 2002 Aug; 2(4):307-18. PubMed ID: 12370052 [TBL] [Abstract][Full Text] [Related]
27. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. Agrawal S; Zhang X; Lu Z; Zhao H; Tamburin JM; Yan J; Cai H; Diasio RB; Habus I; Jiang Z Biochem Pharmacol; 1995 Aug; 50(4):571-6. PubMed ID: 7646565 [TBL] [Abstract][Full Text] [Related]
28. Bioanalysis considerations on the pharmacokinetic evaluation of antisense therapeutics. Norris DA; Post N; Yu RZ; Greenlee S; Wang Y Bioanalysis; 2019 Nov; 11(21):1909-1912. PubMed ID: 31648523 [No Abstract] [Full Text] [Related]
38. Antisense strategy: biological utility and prospects in the treatment of hematological malignancies. Warzocha K; Wotowiec D Leuk Lymphoma; 1997 Jan; 24(3-4):267-81. PubMed ID: 9156656 [TBL] [Abstract][Full Text] [Related]
39. Antisense oligonucleotides: efficient synthesis of 2'-O-methoxyethyl phosphorothioate oligonucleotides using 4,5-dicyanoimidazole. Are these oligonucleotides comparable to those synthesized using 1H-tetrazole as coupling activator? Wang Z; Siwkowski A; Lima WF; Olsen P; Ravikumar VT Bioorg Med Chem; 2006 Jul; 14(14):5049-60. PubMed ID: 16563772 [TBL] [Abstract][Full Text] [Related]
40. An overview of progress in antisense therapeutics. Crooke ST Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):115-22. PubMed ID: 9593049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]